Second MenB Vaccine Dose Offered Following Kent Outbreak
Following a recent, severe outbreak of meningococcal group B disease in Kent, which tragically claimed two lives and infected 19 others, almost 12,000 people will be offered their second dose of the MenB vaccine. This preventative measure is a continuation of the targeted vaccination programme initiated last month.
Vaccination Programme Details
Eligible individuals, including university students residing in Kent halls and those who attended Club Chemistry, a nightclub linked to the outbreak, will be able to book appointments from next week. NHS Kent and Medway has confirmed that clinics will operate in Canterbury, Faversham, and Ashford, with further booking information to be released on Monday.
The second dose of the MenB vaccine is recommended at least four weeks after the first, though it can be administered later. This phased approach is vital for ensuring robust protection against the bacterial strain prevalent in the recent incident.
Context of the Outbreak
The outbreak prompted Health Secretary Wes Streeting to describe the situation as "unprecedented" due to the rapid spread among a concentrated population. Both a 21-year-old university student and sixth-form pupil Juliette Kenny succumbed to the infection, while many others required hospitalisation.
The UK Health Security Agency (UKHSA) declared a national incident to coordinate resources, including the distribution of preventative antibiotics to a broader cohort. The initial vaccination drive, which subsequently expanded to include certain sixth-form students, aimed to contain the spread.
Policy Review
While a routine MenB vaccination programme for infants was introduced in the UK in 2015, a widespread catch-up campaign for teenagers was previously deemed not cost-effective by UK advisers. In light of the recent outbreak, Mr Streeting has requested the Joint Committee on Vaccination and Immunisation (JCVI) to re-evaluate the decision regarding teenage MenB vaccination.
